0. Advocacy Webpage Graphics-Narrow -Standardize It 

There are many misconceptions about the disease of addiction, and a culture change is needed in this country to drive patients to the treatment options that have proven to be effective at reducing overdose deaths and supporting patients in remission and recovery. ASAM advocates for the use of nationally recognized guidelines and standards for the treatment of addiction and the dissemination of competency-based addiction education for all healthcare professionals.





The ASAM Criteria®, the most widely used and comprehensive set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions, is a fundamental tool for the standardization of addiction medicine.



 
ASAM Level of Care Cert final
 



 

Transforming the Delivery of Substance Use Disorder Treatment in States

This slide presentation describes ASAM tools and resources that can help states transform the delivery of substance use disorder treatment.

 




Featured Public Policy Statements

0. doctor patient

Regulation of Office-Based Opioid Treatment

OBOT promotes the treatment of addiction in the primary care setting, but ASAM understands that the use of controlled substances to treat addiction introduces the possibility of misuse and diversion of the very medications used for treatment.
2. medical-recordscrop

Prescription Drug Monitoring Programs (PDMPs)

Find out more about PDMPs and ASAM's recommendations on how they should be regulated.

Worldgen

Joint Public Correctional Policy Statement on the Treatment of Opioid Use Disorders for Justice Involved Individuals

Learn more about how ASAM and the American Correctional Association (ACA) are supporting the use of evidence-based practices for the treatment of opioid use disorders in correctional settings.





"By implementing a quality-driven national addiction treatment infrastructure, we can empower patients and their families with information on how to identify and access high-quality treatment."

-Kelly Clark, MD, MBA, DFASAM
Immediate-Past President of ASAM




Resources

dtd-webpage-title-banner

Appropriate Use of Drug Testing in Clinical Addiction Medicine

Provides guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.

guideline-webpage-title-banner-1

The ASAM National Practice Guideline

The ASAM National Practice Guideline and associated resources provide information on evidence-based treatment of opioid use disorder.

confidentiality_472x176aa36159472bc604ca5b7ff000030b21a

Confidentiality (42 CFR Part 2)

Learn how ASAM continues to call for needed privacy protections as 42 CFR Part 2 regulations and the underlying statute are updated. 




Related News

newspapers-3488857_1920B
  • December 18, 2018

    US Surgeon General Proclaims E-Cigarette Use an Epidemic Among Youth

    US Surgeon General Jerome M. Adams issued a rare public health Advisory declaring the use of e-cigarettes an “epidemic among our nation’s young people.” The Advisory provides information to parents, educators, and health professionals on new types of e-cigarettes on the market, including JUUL, and the negative health consequences of youth use of these products.
  • December 6, 2018

    ASAM Unveils National Public Policy Statement on Substance Use Prevention

    ASAM has released a set of evidence-informed policy recommendations for preventing alcohol and drug-related problems in contemporary society. The policy recommendations were approved by the ASAM Board of Directors and have been endorsed by the American College of Preventive Medicine.
  • October 24, 2018

    Addiction Medicine Leaders Applaud Signing of Historic Opioid Legislation into Law

    The leading association for addiction treatment professionals noted that while H.R. 6 is a critical step toward stemming the nation’s opioid overdose epidemic, more work remains to ensure that patients receive whole-person, evidence-based treatment for opioid use disorder.